Surya Citra Media Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Surya Citra Media Tbk. trades at Rp199 (market cap 12.84T, 43.17M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Surya Citra Media Tbk. is far larger — about 123× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCMA | SCPI | |
|---|---|---|
Market Cap | 12.84T | 104.4B |
Volume | 43.17M | — |
Lot | 431.67K | — |
Turnover | 8.6B | — |
Average Price | 199.25 | — |
Value | 8.6B | — |
Indicative Equilibrium Price | 199 | — |
Indicative Equilibrium Volume | 44.9K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Surya Citra Media Tbk (the Company) formerly PT. Surya Citra Televisi, or popularly known as SCTV, started operations in Surabaya the capital of East Java in 1990 as a regional television station to server the province and the island of Bali. In 1993, pursuant to moving its headquarters to Jakarta, SCTV began broadcasting nationwide. In 29 Jan 1999 PT Cipta Aneka Selaras was established at jakarta and the company changed to PT Surya Citra Media at 31 Dec 2001. PT Elang Mahkota Teknologi Tbk is the ultimate parent company of the Company and Subsidiaries.
Read more on SCMA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →